HIV Vaccine Research Requires Innovative Ideas, New Scientists, More Funding, Researchers Say

Main Category: HIV / AIDS
Also Included In: Immune System / Vaccines
Article Date: 29 Jul 2008 - 12:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  


Current Article Ratings:

Patient / Public:5 stars

5 (1 votes)

Healthcare Prof:not yet rated

Article Opinions: 1 posts

New researchers and innovative ideas are needed to further research on developing an HIV/AIDS vaccine, U.S. scientists wrote in Friday's edition of Science magazine, the AP/Google.com reports. The researchers, including an NIH official, wrote that research should focus on developing a vaccine rather than on clinical trials for medicines that may not be effective. "Design of a vaccine that blocks HIV infection will require enormous intellectual leaps beyond present day knowledge," the researchers wrote.

NIH is looking for "fresh ideas" about developing an HIV/AIDS vaccine and is emphasizing laboratory research to fill knowledge gaps, according to the AP/Google.com. Anthony Fauci, director of NIH's National Institute of Allergy and Infectious Diseases, in a Science podcast said that the failure of a Merck vaccine candidate illustrated that researchers "were maybe on the wrong track a bit." He added, "We will be turning the knob, as I like to say, more preferentially toward answering some of the fundamental questions that have gone unanswered." Increased research in chimpanzees will be a priority, although NIAID will continue to support studies in people under raised standards for federal funding, the AP/Google.com reports.

The need for increased resources aimed at vaccine research comes at a time when NIH's budget remains flat, the researchers wrote. They added that if the agency's budget increases in future years, "one of the highest priorities will be to target those additional resources to HIV vaccine programs, particularly vaccine discovery research" (Freking, AP/Google.com, 7/24).

The researchers' comments in Science follow a summit held by NIAID in March, which was held to re-evaluate vaccine research after the failure of the Merck HIV vaccine candidate in September 2007 (Kaiser Daily HIV/AIDS Report, 3/26).

The issue of Science is available online.

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation.

© 2008 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

Article adapted by Medical News Today from original press release.
Visit our hiv / aids section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Kaiser. "HIV Vaccine Research Requires Innovative Ideas, New Scientists, More Funding, Researchers Say." Medical News Today. MediLexicon, Intl., 29 Jul. 2008. Web.
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/116438.php>

APA
Kaiser. (2008, July 29). "HIV Vaccine Research Requires Innovative Ideas, New Scientists, More Funding, Researchers Say." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/116438.php.

Please note: If no author information is provided, the source is cited instead.




HIV / AIDS

Most Popular Articles



Follow Our HIV News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our HIV / AIDS Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »